Anti-Angiogenic and Cytotoxicity Studies of Some Medicinal Plants

被引:18
|
作者
Ng, Kwok-Wen [1 ]
Salhimi, Salizawati Muhamad [1 ]
Majid, Amin Malik Shah Abdul [1 ]
Chan, Kit-Lam [1 ]
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town 11800, Malaysia
关键词
angiogenesis; cytotoxicity; Phyllanthus species; Euphorbiaceae; Irvingia malayana; Irvingiaceae; betulinic acid; BETULINIC ACID; PHYLLANTHUS-AMARUS; BLUMEA-BALSAMIFERA; ENDOTHELIAL-CELLS; EXTRACT; GROWTH; CANCER; PROLIFERATION; FLAVONOIDS; CARCINOMA;
D O I
10.1055/s-0029-1240813
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Angiogenesis plays an important role in tumor formation and proliferation. The development of anti-angiogenic agents to block new blood vessel growth will inhibit metastasis and induce apoptosis of the cancer cells. Nine medicinal plants, Strobilanthes crispus, Phyllanthus niruri, Phyllanthus pulcher, Phyllanthus urinaria, Ailanthus malabarica, Irvingia malayana, Smilax myosotiflora, Tinospora crispa and Blumea balsamifera were screened for anti-angiogenic properties using the rat aortic ring assay. Of these, the methanol extracts of Phyllanthus species and Irvingia malayana exhibited the highest activity. At 100 mu g/mL, P. pulcher, P. niruri, P. urinaria and I. malayana recorded an inhibition of 78.8%, 59.5%, 56.7% and 46.4%, respectively, against rat aortic vascular growth. Their activities were further investigated by the tube formation assay involving human umbilical vein endothelial cells ( HUVEC) on Matrigel. I. malayana, P. niruri and P. urinaria showed a significant decrease of 45.5, 37.9 and 35.6%, respectively, whilst P. pulcher showed a much lower decrease of 15.5% when compared with that of the rat aortic ring assay. All the plant extracts were evaluated for cytotoxicity on a panel of human cancer cell lines using the MTT assay. None of them displayed acute cytotoxicity. The HPLC of P. niruri, P. urinaria and P. pulcher indicated the extracts contained some identical chromatographic peaks of lignans. Further fractionation of I. malayana yielded betulinic acid reported in this plant for the first time and at 100 mu g/mL it exhibited a 67.3% inhibition of vessel outgrowth and 46.5% inhibition of tube formation.
引用
收藏
页码:935 / 940
页数:6
相关论文
共 50 条
  • [1] Anti-angiogenic activity of Middle East medicinal plants of the Lamiaceae family
    Abdallah, Qasem
    Al-Deeb, Ibrahim
    Bader, Ammar
    Hamam, Fayez
    Saleh, Kamel
    Abdulmajid, Amin
    MOLECULAR MEDICINE REPORTS, 2018, 18 (02) : 2441 - 2448
  • [2] Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants
    Cao, Y
    Fu, ZD
    Wang, F
    Liu, HY
    Han, R
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2005, 7 (03) : 205 - 213
  • [3] Evaluation of anti-breast cancer, anti-angiogenic and antioxidant properties of selected medicinal plants
    Kamble, Sonali S.
    Gacche, Rajesh N.
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2019, 25 : 13 - 19
  • [4] Anti-Angiogenic and Cytotoxicity Effects of Selachyl Alcohol Analogues
    Pemha, Rene
    Le Bot, Damien
    Mosset, Paul
    Legrand, Alain Bernard
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (10) : 1913 - 1920
  • [5] Ethnopharmacological evaluation of antioxidant, anti-angiogenic, and anti-inflammatory activity of some traditional medicinal plants used for treatment of cancer in Togo/Africa
    Kola, P.
    Metowogo, K.
    Manjula, S. N.
    Katawa, G.
    Elkhenany, H.
    Mruthunjaya, K. M.
    Eklu-Gadegbeku, K.
    Aklikokou, K. A.
    JOURNAL OF ETHNOPHARMACOLOGY, 2022, 283
  • [6] A is for anti-angiogenic
    不详
    NATURE MEDICINE, 2001, 7 (04) : 418 - 418
  • [7] The anti-angiogenic properties of Mistletoe extracts is associated with endothelial cytotoxicity
    Elluru, S.
    Duong Van Huyen, J.
    Delignat, S.
    Frost, F.
    Bayry, J.
    Kaveri, S.
    EJC SUPPLEMENTS, 2006, 4 (12): : 158 - 159
  • [8] ANTI-ANGIOGENIC ISOFORMS OF VEGF - A KEY TO ANTI-ANGIOGENIC THERAPY
    Bates, D. O.
    Harper, S. J.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3207 - 3208
  • [9] Anti-angiogenic drugs in cancer therapeutics: a review of the latest preclinical and clinical studies of anti-angiogenic agents with anticancer potential
    Vafopoulou, Polyxeni
    Kourti, Malamati
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8
  • [10] Anti-angiogenic immunotherapy
    Schoenfeld, Jonathan D.
    Dranoff, Glenn
    HUMAN VACCINES, 2011, 7 (09): : 976 - 981